Entasobulin
Modify Date: 2024-01-11 16:39:22
Entasobulin structure
|
Common Name | Entasobulin | ||
|---|---|---|---|---|
| CAS Number | 501921-61-5 | Molecular Weight | 439.893 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C26H18ClN3O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of EntasobulinEntasobulin is a β-tubulin polymerization inhibitor with potential anticancer activity. |
| Name | Entasobulin |
|---|---|
| Synonym | More Synonyms |
| Description | Entasobulin is a β-tubulin polymerization inhibitor with potential anticancer activity. |
|---|---|
| Related Catalog | |
| Target |
β-tubulin polymerization |
| In Vitro | Entasobulin is a indolizine-glyoxylamide based small molecule that demonstrate substantial in vitro anti-proliferative activities against cancer cell lines, including multidrug resistance (MDR) phenotypes. |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Molecular Formula | C26H18ClN3O2 |
| Molecular Weight | 439.893 |
| Exact Mass | 439.108765 |
| LogP | 5.36 |
| Index of Refraction | 1.683 |
| Storage condition | 2-8℃ |
| 2-[1-(4-chlorobenzyl)-1H-indol-3-yl]-2-oxo-N-(quinolin-6-yl)acetamide |
| 1H-Indole-3-acetamide, 1-[(4-chlorophenyl)methyl]-α-oxo-N-6-quinolinyl- |
| entasobulin |
| TB77GU6BFO |
| 2-[1-(4-Chlorobenzyl)-1H-indol-3-yl]-2-oxo-N-(6-quinolinyl)acetamide |